Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"The Effect of Probiotics on the Degree of Dyspnea, Lung Function, and Inflammatory Mediators in Patients With Chronic Obstructive Pulmonary Disease (COPD)."

NCT07339280 is registered in ClinicalTrials.gov with University Hospital of Split as lead sponsor.

NCT NCT07339280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07339280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"The Effect of Probiotics on the Degree of Dyspnea, Lung Function, and Inflammatory Mediators in Patients With Chronic Obstructive Pulmonary Disease (COPD)."
Lead sponsor
University Hospital of Split
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 8, 2026
Completion date
December 31, 2030
Enrollment
60 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

copd, copd (chronic obstructive pulmonary disease), probiotic, probiotic supplement